Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.170
-0.020 (-1.68%)
At close: Jan 9, 2026, 4:00 PM EST
1.240
+0.070 (5.98%)
After-hours: Jan 9, 2026, 7:51 PM EST
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $20.32 million as of January 9, 2026. Its market cap has increased by 340.62% in one year.
Market Cap
20.32M
Enterprise Value
4.81M
1-Year Change
340.62%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $20.32M, a decrease of -74.41%. That is a compound annual growth rate of -28.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 20.32M | 8.33% |
| Dec 31, 2025 | 18.75M | 261.53% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |